Adult-Onset Neurodegeneration Has Roots in Early Development
Neurofascin staining reveals processes of basket cells surrounding Purkinje neurons in the cerebellum. Credit: Feinberg School of Medicine, Northwestern University
The disease mechanism for adult-onset progressive degenerative diseases begins much earlier than previously thought, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
Using a mouse model of spinocerebellar ataxia type 1 (SCA1) genetically engineered to precisely mirror the human disease, a team of investigators showed that there is an altered neural circuitry in the cerebellum that sets the stage for later disease vulnerability.
These findings are important since they raise the possibility that other adult-onset neurodegenerative diseases have their roots in early developmental defects, with implications for pathogenesis and treatment, said Puneet Opal, MD, PhD, professor in the Ken & Ruth Davee Department of Neurology in the Division of Movement Disorders and senior author on the study.
“This is the first discovery of alterations in an adult-onset spinocerebellar disorder that stem from such early developmental processes,” said Opal, also a professor of Cell and Molecular Biology. “This may well be generalizable to a whole host of other diseases, including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.”
SCA1 is caused by a genetic defect in a protein involved in regulating gene expression called ATXN1. While ATXN1 is expressed throughout the brain, when mutated it predominantly affects the cerebellum, leading to a loss of coordination and an abnormal gait in patients.
Previous studies have largely focused on neurons in the disease, but Opal and his colleagues theorized the cerebellar stem cell population might also behave differently since some of the gene expression changes in the brain in the disease occur relatively early.
Using a genetically engineered mouse model of the disease, the scientists found that mutant ATXN1 had surprising effects on postnatal cerebellar stem cells.
Puneet Opal, MD, PhD, professor of Neurology in the Division of Movement Disorders and of Cell and Molecular Biology, was senior author of a paper published in the Journal of Clinical Investigation.
“We were amazed to find that they multiplied excessively and tended to differentiate into inhibitory neurons called basket cells,” Opal said. “We knew that cerebellar stem cells generate inhibitory neurons, but in this case the number of inhibitory neurons was so much more than normal that they generated an enhanced inhibitory effect on Purkinje neurons, the chief output neurons of the cerebellum. This results in a very different cerebellar network.”
These changes began in the early postnatal weeks of life and may explain why the cerebellar neuronal network is particularly vulnerable to degeneration in patients with SCA1, according to Opal.
In addition, as more stem cells became inhibitory neurons, fewer stem cells became brain cells called astrocytes, possibly further disrupting normal cerebellar function.
“This network dysfunction could be a constant stress, and that constant stress makes the neural network deteriorate over time,” Opal said.
While it’s still unclear exactly how the mutant protein is causing these changes, according to the study, the findings underscore the need to study a relatively underappreciated phenomenon: that pathogenic processes in neurodegenerative diseases begin very early in life — well before signs or symptoms are noticed.
“Other diseases may have similar developmental defects, but we haven’t looked for them,” Opal said. “We found them in SCA1, but it could be true for the other diseases as well.”
This article has been republished from materials provided by Northwestern Feinberg School of Medicine. Note: material may have been edited for length and content. For further information, please contact the cited source.
Edamakanti, C. R., Do, J., Didonna, A., Martina, M., & Opal, P. (2018). Mutant ataxin1 disrupts cerebellar development in spinocerebellar ataxia type 1. The Journal of clinical investigation, 128(6).
We make judgements quite rationally or "by the gut". Not only experience and relevant information play an important role, but also our preferences. A study by the Max Planck Institute for Metabolism Research in Cologne shows how the reward system in the brain conveys judgements affected by one's own desires, and how our inner beliefs are altered more by good than bad news.
The emerging technology of sonogenetics—a technique where cells are controlled by sound—offers the potential to one day replace pharmaceutical drugs or invasive surgical treatments for neurological conditions like epilepsy, Parkinson’s disease or post-traumatic stress disorder. A new research program could take this technique to the next level with $750,000 of funding.READ MORE
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019
4th Annual Congress on Nanomedicine and Drug Delivery
Apr 04 - Apr 06, 2019